Loading...
Straumann Holding AG
SAUHF•PNK
Healthcare
Medical - Instruments & Supplies
$124.42
$-0.13(-0.11%)
Straumann Holding AG (SAUHF) Financial Performance & Income Statement Overview
Review Straumann Holding AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.82%
↑ 3.82%
Operating Income Growth
46.24%
↑ 46.24%
Net Income Growth
57.81%
↑ 57.81%
Operating Cash Flow Growth
-4.08%
↓ 4.08%
Operating Margin
18.12%
↑ 18.12%
Gross Margin
72.20%
↑ 72.20%
Net Profit Margin
10.97%
↑ 10.97%
ROE
13.51%
↑ 13.51%
ROIC
16.71%
↑ 16.71%
Straumann Holding AG (SAUHF) Income Statement & Financial Overview
Review Straumann Holding AG's (SAUHF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $1.27B | $1.19B | $1.22B | $1.14B |
| Cost of Revenue | $353.34M | $332.86M | $305.91M | $331.68M |
| Gross Profit | $919.89M | $862.08M | $910.98M | $810.76M |
| Gross Profit Ratio | $0.72 | $0.72 | $0.75 | $0.71 |
| R&D Expenses | $0.00 | $111.10M | $0.00 | $104.60M |
| SG&A Expenses | $588.06M | $750.89M | $618.27M | $602.46M |
| Operating Expenses | $583.83M | $750.89M | $618.27M | $602.46M |
| Total Costs & Expenses | $937.17M | $1.08B | $924.18M | $934.14M |
| Interest Income | $88.60M | $70.50M | $40.39M | $46.15M |
| Interest Expense | $94.10M | $90.32M | $76.85M | $69.22M |
| Depreciation & Amortization | $70.39M | $67.30M | $62.94M | $104.90M |
| EBITDA | $408.60M | $178.48M | $386.91M | $313.20M |
| EBITDA Ratio | $0.32 | $0.15 | $0.29 | $0.27 |
| Operating Income | $336.06M | $111.19M | $292.71M | $208.30M |
| Operating Income Ratio | $0.26 | $0.09 | $0.24 | $0.18 |
| Other Income/Expenses (Net) | -$11.36M | -$16.62M | -$17.62M | -$19.92M |
| Income Before Tax | $324.70M | $94.57M | $260.12M | $188.38M |
| Income Before Tax Ratio | $0.26 | $0.08 | $0.21 | $0.16 |
| Income Tax Expense | $56.47M | $49.34M | $49.47M | $13.23M |
| Net Income | $230.37M | $40.30M | $205.78M | $169.39M |
| Net Income Ratio | $0.18 | $0.03 | $0.17 | $0.15 |
| EPS | $1.45 | $0.25 | $1.29 | $1.06 |
| Diluted EPS | $1.44 | $0.25 | $1.29 | $1.06 |
| Weighted Avg Shares Outstanding | $159.40M | $159.44M | $159.36M | $159.35M |
| Weighted Avg Shares Outstanding (Diluted) | $159.45M | $159.48M | $159.63M | $159.35M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan